Provided by Tiger Fintech (Singapore) Pte. Ltd.

Avis Budget

105.84
-0.5100-0.48%
Pre-market: 106.000.1600+0.15%08:00 EDT
Volume:730.78K
Turnover:77.31M
Market Cap:3.72B
PE:-1.69
High:107.02
Open:105.98
Low:103.98
Close:106.35
Loading ...

Q4 Earnings Roundup: RXO (NYSE:RXO) And The Rest Of The Ground Transportation Segment

StockStory
·
25 Feb

Anixa Biosciences Featured in Breaking Cancer News Article on Novel CAR-T Therapy for Ovarian Cancer

PR Newswire
·
24 Feb

BioNTech to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Update on March 10, 2025

GlobeNewswire
·
24 Feb

Unpacking Q4 Earnings: Werner (NASDAQ:WERN) In The Context Of Other Ground Transportation Stocks

StockStory
·
24 Feb

Cellectis Presents ‘Smart CAR T’ Strategy to Enhance Efficacy Against Solid Tumors at AACR-IO 2025

GlobeNewswire
·
24 Feb

Transport stocks take a hit on Wall Street on economic and tariff fears

Reuters
·
22 Feb

BUZZ-Transport stocks sink amid economy, tariff worries

Reuters
·
22 Feb

Winners And Losers Of Q4: Old Dominion Freight Line (NASDAQ:ODFL) Vs The Rest Of The Ground Transportation Stocks

StockStory
·
21 Feb

Hemogenyx Pharmaceuticals Secures Funding to Advance CAR-T Therapy Trials

TIPRANKS
·
20 Feb

Ground Transportation Stocks Q4 Teardown: Avis Budget Group (NASDAQ:CAR) Vs The Rest

StockStory
·
19 Feb

Biocurious: Cashed up and pursuing the ‘c’ word, Imugene is on the verge of transforming cancer immunotherapy

Stockheads
·
19 Feb

Stock Track | Avis Budget Soars 5.13% on Tuesday After Barclays Reaffirms Hold Rating

Stock Track
·
19 Feb

Carclo plc Sees Increased Stake by First Equity Limited

TIPRANKS
·
19 Feb

Anixa Biosciences: Advancing CAR-T Therapy and Cancer Vaccines with Strategic Trial Amendments and Robust Financial Position

TIPRANKS
·
19 Feb

Baird ‘encouraged’ by Allogene CAR-T therapy update

TIPRANKS
·
19 Feb

Avalon granted Notice of Allowance for CAR-T and CAR-NK cell technology in China

TIPRANKS
·
18 Feb

Anixa Biosciences announces approval of protocol amendment for CAR-T trial

TIPRANKS
·
18 Feb

Barclays Reaffirms Their Hold Rating on Avis Budget (CAR)

TIPRANKS
·
18 Feb

Celyad Oncology announces the publication of the preclinical and clinical data of CYAD-211 providing proof-of-concept of its miRNA-based shRNA platform

Business Wire
·
18 Feb

Analysts’ Opinions Are Mixed on These Industrial Goods Stocks: Avis Budget (CAR), A. O. Smith Corporation (AOS) and Ingersoll Rand (IR)

TIPRANKS
·
18 Feb